Australia Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Australia Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices


  • Products Id :- GDMEMC0252DB
  • |
  • Pages: 132
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Australia Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "Australia Drug Delivery Devices Market Outlook to 2023", provides key market data on the Australia Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the Australia Drug Delivery Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Drug Delivery Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Drug Delivery Devices Market, Australia 11

3.1 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2023 11

3.2 Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016 13

3.3 Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016 14

3.4 Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15

3.5 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2016 16

3.6 Drug Delivery Devices Market, Australia, Revenue ($m), 2016-2023 18

3.7 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 20

3.8 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2016 22

3.9 Drug Delivery Devices Market, Australia, Volume (Units), 2016-2023 24

3.10 Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), 2016 26

4 Central Venous Catheters Market, Australia 28

4.1 Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016 28

4.2 Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29

4.3 Central Venous Catheters Market, Australia, Revenue ($m), 2009-2016 30

4.4 Central Venous Catheters Market, Australia, Revenue ($m), 2016-2023 32

4.5 Central Venous Catheters Market, Australia, Volume (Units), 2009-2016 34

4.6 Central Venous Catheters Market, Australia, Volume (Units), 2016-2023 36

4.7 Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), 2015-2016 38

4.8 Central Venous Catheters Market, Australia, Company Share by Revenue ($m), 2016 39

5 Infusion Systems Market, Australia 41

5.1 Infusion Systems Market, Australia, Revenue Mix ($m), 2016 41

5.2 Infusion Systems Market, Australia, Segment Contribution (%), 2016 42

5.3 Infusion Systems Market, Australia, Revenue ($m), 2009-2016 43

5.4 Infusion Systems Market, Australia, Revenue ($m), 2016-2023 45

5.4.1 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016 47

5.4.2 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016 49

5.4.3 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023 51

5.4.4 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023 53

5.5 Infusion Systems Market, Australia, Volume (Units), 2009-2016 55

5.6 Infusion Systems Market, Australia, Volume (Units), 2016-2023 57

5.6.1 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2009-2016 59

5.6.2 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2009-2016 61

5.6.3 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2016-2023 63

5.6.4 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2016-2023 65

5.7 Infusion Systems Market, Australia, Distribution Share by Revenue ($m), 2015-2016 67

5.8 Infusion Systems Market, Australia, Company Share by Revenue ($m), 2016 68

6 Needle Free Injections Market, Australia 70

6.1 Needle Free Injections Market, Australia, Revenue ($m), 2009-2016 70

6.2 Needle Free Injections Market, Australia, Revenue ($m), 2016-2023 71

6.3 Needle Free Injections Market, Australia, Volume (Units), 2009-2016 72

6.4 Needle Free Injections Market, Australia, Volume (Units), 2016-2023 73

6.5 Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), 2015-2016 74

6.6 Needle Free Injections Market, Australia, Company Share by Revenue ($m), 2016 75

7 Metered Dose Inhaler Devices Market, Australia 77

7.1 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2009-2016 77

7.2 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2016-2023 78

7.3 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2009-2016 79

7.4 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2016-2023 80

7.5 Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), 2015-2016 81

7.6 Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), 2016 82

8 Overview of Key Companies in Australia, Drug Delivery Devices Market 84

8.1 Teleflex Inc 84

8.1.1 Company Overview 84

8.2 GlaxoSmithKline Plc 84

8.2.1 Company Overview 84

8.3 AstraZeneca Plc 84

8.3.1 Company Overview 84

8.4 Becton Dickinson and Co 84

8.4.1 Company Overview 84

8.5 Boehringer Ingelheim GmbH 85

8.5.1 Company Overview 85

8.6 Baxter International Inc 85

8.6.1 Company Overview 85

8.7 Fresenius Kabi AG 85

8.7.1 Company Overview 85

8.8 Pfizer Inc 86

8.8.1 Company Overview 86

8.9 B. Braun Melsungen AG 86

8.9.1 Company Overview 86

8.10 Smiths Medical 86

8.10.1 Company Overview 86

8.11 Merck & Co Inc 87

8.11.1 Company Overview 87

8.12 Hospira Inc 87

8.12.1 Company Overview 87

8.13 Terumo Corp 87

8.13.1 Company Overview 87

8.14 Nipro Corp 87

8.14.1 Company Overview 87

8.15 Medtronic plc 88

8.19.1 Company Overview 88

9 Drug Delivery Devices Market Pipeline Products 89

10 Financial Deals Landscape 94

10.1 Asset Transactions 94

10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94

10.2 Debt Offerings 96

10.2.1 Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019 96

10.3 Equity Offerings 97

10.3.1 Suda Raises USD1.1 Million in Private Placement of Shares 97

10.3.2 Admedus Raises USD7.5 Million in Private Placement of Shares 99

10.3.3 Admedus Raises USD4 Million in Rights Offering of Shares 100

10.4 Partnerships 101

10.4.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 101

10.4.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 102

10.4.3 Pfizer Terminates its Licensing Agreement with pSivida 104

10.4.4 Bayer Enters into Licensing Agreement with DelSiTech 105

10.4.5 BioCorRx Enters into Licensing Agreement with Therakine 106

11 Recent Developments 107

11.1 Corporate Communications 107

11.1.1 Jun 09, 2017: Admedus Appoints David St. Denis as Chief Operating Officer 107

11.1.2 May 23, 2017: Analytica: Appointment of Dr. Peter B. Corr as Director 107

11.1.3 Apr 21, 2017: Phosphagenics Announces Transition of Chairman of the Board 108

11.1.4 Apr 04, 2017: GSK responds to Cyclone Debbie 109

11.1.5 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer 109

11.1.6 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman 110

11.1.7 Dec 12, 2016: Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option 111

11.1.8 Dec 08, 2016: Acrux Announces Director Resignation 112

11.1.9 Oct 17, 2016: Medrobotics Corporation Receives Expanded CE Mark for Flex Robotic System 112

11.1.10 Sep 25, 2016: Admedus Strengthens Management Team 113

11.1.11 Sep 15, 2016: Anne Belcher to succeed Geoff McDonald as GSK Australia general manager 113

11.1.12 Aug 26, 2016: Admedus Appoints New Chief Financial Officer 114

11.2 Financial Announcements 114

11.2.1 May 02, 2017: GSK Australia Reports 2016 results to ASIC 114

11.2.2 Apr 28, 2017: Clinuvel Pharmaceuticals: Appendix 4C-Quarterly report 115

11.2.3 Feb 28, 2017: Phosphagenics Full Year Financial Results 116

11.2.4 Feb 24, 2017: Admedus Announces Half Yearly Report 117

11.2.5 Feb 23, 2017: ITL Profit Doubles In Half Year 2016/2017 Results 118

11.2.6 Feb 20, 2017: Medical Developments Reports Revenue Of AUD8m In H1 Fiscal 2017 118

11.2.7 Oct 31, 2016: Suda: Appendix 4C For First Quarter Fy 2017 119

11.2.8 Oct 28, 2016: Analytica: Appendix 4C-Quarterly Cash Flow Report 119

11.2.9 Aug 31, 2016: Analytica Announces 2016 Full Year Results 119

11.2.10 Aug 24, 2016: Acrux: Financial Report for the year ended 30 June 2016 120

11.2.11 Jul 20, 2016: Admedus Announces Financial Report 121

11.3 Legal And Regulatory 122

11.3.1 May 29, 2017: Phosphagenic-Mylan Arbitration Update-expert report on quantum of damages claimed filed 122

11.3.2 Jan 20, 2017: Change of Registered Office and Principal Place of Business 122

11.3.3 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings 122

11.4 Other Significant Developments 123

11.4.1 Apr 26, 2017: Axiron Net Sales, quarter to March 2017 123

11.4.2 Apr 13, 2017: PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest 123

11.4.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 124

11.4.4 Jan 31, 2017: Analytica Releases Quarterly Cash Flow Report 125

11.4.5 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review 125

11.4.6 Oct 28, 2016: Starpharma Quarterly Cashflow Report 126

11.5 Product News 127

11.5.1 Oct 26, 2016: Starpharma to present at US Drug Delivery Conference 127

12 Appendix 128

12.1 Research Methodology 129

12.1.1 Coverage 129

12.1.2 Secondary Research 129

12.1.3 Primary Research 130

12.1.4 Company Share Analysis 130

12.1.5 Distribution Share Analysis 130

12.1.6 Benchmarking 131

12.2 GlobalData Consulting 131

12.3 Contact Us 132

12.4 Disclaimer 132

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023 11

Figure 2: Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016 13

Figure 3: Drug Delivery Devices Market, Australia, Category Contribution (%), 2016 14

Figure 4: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15

Figure 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 16

Figure 6: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 18

Figure 7: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 20

Figure 8: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016 22

Figure 9: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023 24

Figure 10: Drug Delivery Devices Market, Australia, Company Share (%) 2016 26

Figure 11: Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016 28

Figure 12: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29

Figure 13: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 30

Figure 14: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 32

Figure 15: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016 34

Figure 16: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023 36

Figure 17: Central Venous Catheters Market, Australia, Company Share (%) 2016 39

Figure 18: Infusion Systems Market, Australia, Revenue Mix ($m), 2016 41

Figure 19: Infusion Systems Market, Australia, Segment Contribution (%), 2016 42

Figure 20: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 43

Figure 21: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 45

Figure 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 47

Figure 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 49

Figure 24: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 51

Figure 25: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Figure 26: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016 55

Figure 27: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023 57

Figure 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016 59

Figure 29: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016 61

Figure 30: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 63

Figure 31: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 65

Figure 32: Infusion Systems Market, Australia, Company Share (%) 2016 68

Figure 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 70

Figure 34: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 71

Figure 35: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016 72

Figure 36: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023 73

Figure 37: Needle Free Injections Market, Australia, Company Share (%) 2016 75

Figure 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 77

Figure 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 78

Figure 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016 79

Figure 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023 80

Figure 42: Metered Dose Inhaler Devices Market, Australia, Company Share (%) 2016 82

1.1 List of Tables

Table 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023 12

Table 2: Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016 14

Table 3: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15

Table 4: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 17

Table 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Table 6: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 21

Table 7: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016 23

Table 8: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023 25

Table 9: Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 27

Table 10: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29

Table 11: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 31

Table 12: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Table 13: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016 35

Table 14: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023 37

Table 15: Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38

Table 16: Central Venous Catheters Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 40

Table 17: Infusion Systems Market, Australia, Segment Contribution (%), 2016 42

Table 18: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 44

Table 19: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 46

Table 20: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 48

Table 21: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 50

Table 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 52

Table 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Table 24: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016 56

Table 25: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023 58

Table 26: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016 60

Table 27: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016 62

Table 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 64

Table 29: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 66

Table 30: Infusion Systems Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 67

Table 31: Infusion Systems Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 69

Table 32: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 70

Table 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 71

Table 34: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016 72

Table 35: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023 73

Table 36: Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 74

Table 37: Needle Free Injections Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 76

Table 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 77

Table 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 78

Table 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016 79

Table 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023 80

Table 42: Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 81

Table 43: Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 83

Table 44: Drug Delivery Devices Market Pipeline Products 89

Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94

Table 46: Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019 96

Table 47: Suda Raises USD1.1 Million in Private Placement of Shares 97

Table 48: Admedus Raises USD7.5 Million in Private Placement of Shares 99

Table 49: Admedus Raises USD4 Million in Rights Offering of Shares 100

Table 50: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 101

Table 51: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 102

Table 52: Pfizer Terminates its Licensing Agreement with pSivida 104

Table 53: Bayer Enters into Licensing Agreement with DelSiTech 105

Table 54: BioCorRx Enters into Licensing Agreement with Therakine 106

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Teleflex Inc

GlaxoSmithKline Plc

AstraZeneca Plc

Becton Dickinson and Co

Boehringer Ingelheim GmbH

Baxter International Inc

Fresenius Kabi AG

Pfizer Inc

B. Braun Melsungen AG

Smiths Medical

Merck & Co Inc

Hospira Inc

Terumo Corp

Nipro Corp

Medtronic plc

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 5995 INR 399207
Site License
USD 11990 INR 798414
Corporate User License
USD 17985 INR 1197621

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com